Staff turnover in EUR262,125231,643282,193291,062240,511
Staff turnover in EUR262,125231,643282,193291,062240,511
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)39.6039.6039.6039.6039.60
Dividend per share0.040.04-0.080.04
Basic earnings per share-1.61-0.813.200.66-1.80
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover515.6516.1684.6726.2648.9
Operating income (EBIT)-49.0-8.2141.190.4-55.0
Earnings before taxes-63.9-29.8106.360.6-93.3
Annual net profit/ loss-63.4-31.7127.026.4-70.7
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets522.2619.4756.5809.5873.8
Total fixed assets608.8612.3687.8634.8666.0
Total assets1,131.01,231.71,444.31,444.31,539.8
Liabilities
Total short-term liabilities106.4130.2385.3160.1155.3
Total long-term liabilities644.2730.4560.1753.5921.0
Total provisions118.887.795.9105.5102.8
Equity capital380.4371.1498.9530.7463.5
Total liabilities1,131.01,231.71,444.31,444.31,539.8
Management:
Jörg Schüttrumpf
Board:
Bernhard R. M. Ehmer
David Ian Bell
Gernot Hebestreit
Dirk Schuck
Raimon Grifols Roura
Susanne Butler
Shareholding in %:
Arvernus Capital AG 0.07
Grifols SA 97.14
Freefloat 2.79
Address: Landsteinerstrasse 5, 63303 Dreieich
T: +49-6103-801-0
F: +
I: http://www.biotest.de
E: [email protected]